IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial

Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...

Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer

Positive results from the VOLGA Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with neoadjuvant enfortumab vedotin (EV) demonstrated ...
Medindia

Women Turn to Social Media to Break UTI Stigma

Women are breaking the silence on chronic UTIs through social media, raising awareness of symptoms, stigma, and diagnosis ...
News9Live on MSN

Silent damage of everyday habits: How your phone, chair and sleeping position affect your spine

Stiff necks, backaches and headaches are often overlooked, yet how you use your phone, sit at work, and sleep can harm your ...
Daily Star

Drug addict turned yellow and bladder shrank to 'teaspoon' as parents told 'say goodbye'

Georgia Lee Hampshire, 27, was taking up to 14g of a drug every day at the height of her 10-year addiction, suffering ...
Money Today

"Cola-colored blood in urine" But no pain? The more dangerous reason

Professor Chung Seung-il, Department of Urology, Hwasun Chonnam National University Hospital. /Photo provided by=Hwasun ...

UTI symptoms but a negative urine test? Why your bladder pain may have another cause

Millions of women experience recurring UTI symptoms, but what if the cause is not a bacterial infection? Doctors explain why ...
Newspoint on MSN

Back pain causes: 7 everyday habits that may be hurting your spine and how to prevent them

Back Pain Causes and Prevention: Back pain is no longer a concern limited to older adults. Many young professionals, students ...